from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2186c/-

LFCtreatmentdescriptionclass of inhibitor

0.476

Amikacinug/mL Amikacintranslation

1.681

Cap5-10ug/mL Capreomycintranslation

1.919

Rox10-50 ug/mL Roxithromycintranslation

0.865

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.553

Rif0.2-5ug/mL Rifampicintranscription

0.297

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.159

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.070

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.116

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.536

Clofazimine10-13 ug/mL Clofaziminerespiration

0.167

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.422

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.584

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.196

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.162

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.325

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.700

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.499

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.017

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.617

KCN5-20 ug/mL Potassium cyaniderespiration

1.546

NaN30.2-2 mM Sodium aziderespiration

0.217

Nigericin50 uM Nigericinrespiration

0.740

TRC10-150 ug/mL Triclosanrespiration

-0.087

TRZ10-25 ug/mL Thioridazinerespiration

-0.272

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.317

menadione6-10 ug/mL Menadionerespiration

-0.763

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.514

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.609

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.294

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.027

NRP_1Non-replicating persistence stage 1dosRassociated

-0.158

Amp0.2mg/mL AmpicillincellWall

0.188

Cephalexin20-100 ug/mL CephalexincellWall

-0.036

Cerulenin0.32-5 ug/mL CerulenincellWall

0.445

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.462

EMB10-20 ug/mL EthambutolcellWall

1.060

Eta12-40 ug/mL EthionamidecellWall

0.372

INH0.2-0.4 ug/mL IsoniazidcellWall

0.766

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.156

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.142

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.793

BZA0.12 mg/mL BenzamidearomaticAmides

-0.104

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.097

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.383

H2O24 mM hydrogen peroxideDNAdamaging

-0.066

Levo10 ug/mL LevofloxacinDNAdamaging

0.001

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.817

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.322

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.214

UVUV-irradiationDNAdamaging

-1.039

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.509

Antimycin12.5-50 ug/mL Antimycin A?

-0.424

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.080

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.337

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.346

PA8240.2-2 ug/mL PA-824?

-0.542

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.082

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.887

Verapamil50 uM Verapamil?

-0.526

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.458

methoxatin10-20 ug/mL Methoxatin?